Crossmark

Evaluation of the Clinitek®, a point-of-care urinalysis system for the measurement of clinically significant urinary metabolites and detection of haematuria in Schistosoma haematobium infected children in southern Côte d’Ivoire

Crossref DOI link: https://doi.org/10.1186/s13071-019-3555-z

Published Online: 2019-06-13

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Panic, Gordana https://orcid.org/0000-0002-6423-3183
Barda, Beatrice

Kovač, Jana

Coulibaly, Jean T.

Keiser, Jennifer https://orcid.org/0000-0003-0290-3521
Funding

Funding for this research was provided by:

European Research Council (614739)
License Information

Text and Data Mining valid from 2019-06-13

Version of Record valid from 2019-06-13
More Information

Article History

Received: 11 April 2019

Accepted: 5 June 2019

First Online: 13 June 2019

Ethics approval and consent to participate

: Ethics committees in both Basel (Ethikkommission beider Basel-EKBB; EKNZ 162/2014) and the Ministère de la Santé et de l’Hygiène Publique in Côte d’Ivoire (CNER, 037/MSLS/CNER-dnk), approved the study and the trial was also registered as an International Standard Randomised Controlled Trial (ISRCTN15280205).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below